Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Interstitial Lung Disease Clinical Trials

104 recruiting trials for Interstitial Lung Disease. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
104
Total Trials
104
Recruiting Now
10
Phase 3 Trials
10
Sponsors

Recruiting Trials

RECRUITINGNCT07301892

Generative AI Impact on Rheumatoid Arthritis Complications Diagnosis

Generative AI (GenAI) based on large language models (LLMs) is expected to improve the diagnosis and treatment of autoimmune diseases. We are studying how GenAI may affect the...

Sponsor: Guang'anmen Hospital of China Academy of Chinese Medical SciencesEnrolling: 1001 location
RECRUITINGPhase 3NCT07179380

Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension...

The primary objective of this study is to evaluate the effect of 24-weeks of once daily treatment with TPIP versus placebo on exercise capacity in adults with PH-ILD.

Sponsor: Insmed IncorporatedEnrolling: 34420 locations
RECRUITINGPhase 2NCT03630211

Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis

The purpose of this study is to determine whether a regimen of high-dose immunoablative therapy will demonstrate safety that is consistent or improved with other published...

Sponsor: Paul SzabolcsEnrolling: 83 locations
RECRUITINGNCT06476470

Taiwan Interstitial Lung Disease Multi-center Investigation and Registry

The Taiwan Interstitial Lung Disease (ILD) Multi-center Investigation and Registry aims to evaluate the long-term outcomes of patients with fibrotic interstitial lung disease....

Sponsor: Taichung Veterans General HospitalEnrolling: 100001 location
RECRUITINGNCT05776225

Pulmonary Hypertension Screening in Patients With Interstitial Lung Disease for Earlier Detection

Study GMS-PH-001 is a multicenter, open-label, non-randomized study to prospectively evaluate screening strategies of pulmonary hypertension (PH) in patients with interstitial...

Sponsor: United TherapeuticsEnrolling: 30020 locations
RECRUITINGPhase 1NCT04624490

Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease

The purpose of this study is to develop and evaluate the usefulness of hyperpolarized (HP) 129Xe gas MRI for regional assessment of pulmonary function.

Sponsor: Mario Castro, MD, MPHEnrolling: 2601 location
RECRUITINGNCT06235645

dEtection of rheumAtoid aRthritis - Interstitial Lung dIseasE by Thoracic ultRasound

Rheumatoid arthritis is an autoimmune disease that can affect various organs, including the lungs, and lead to rheumatoid arthritis-interstitial lung disease (RA-ILD). RA-ILD is...

Sponsor: University Hospital, ToursEnrolling: 2801 location
RECRUITINGNCT07320846

The Effect of Exercise Training on lncRNA Expression in Rheumatoid Arthritis

The goal of this observational study is to examine the effects of traditional respiratory rehabilitation and respiratory muscle strengthening training added to this program at the...

Sponsor: Saglik Bilimleri UniversitesiEnrolling: 391 location
RECRUITINGNCT05391100

Screening of Patients With Rheumatoid Arthritis for Interstitial Lung Disease

The quantitative and qualitative analysis of RA lung involvement in the Hungarian population

Sponsor: Polyclinic of the Hospitaller Brothers of St. John of God, BudapestEnrolling: 5003 locations
RECRUITINGNCT03297775

Rheumatoid Arthritis Patients at Risk for Interstitial Lung Disease

The overall goal of this study is to define the phenotype of Interstitial Lung Disease (ILD), and identify factors that predict radiologic progression in those with subclinical...

Sponsor: University of Colorado, DenverEnrolling: 7501 location
RECRUITINGPhase 4NCT07077486

Effects of Telitacicept vs Cyclophosphamide on Lupus Related Interstitial Lung Disease

Recent data indicate that Telitacicept is beneficial for lupus nephritis. Our goal is to determine whether Telitacicept is an effective and safe treatment, compared to...

Sponsor: Tongji HospitalEnrolling: 1001 location
RECRUITINGPhase 2NCT05785065

Mycophenolate Mofetil in Systemic Sclerosis With Subclinical Interstitial Lung Disease

The goal of this pilot study is to assess the feasibility of a larger study on the efficacy of mycophenolate mofetil in people diagnosed with systemic sclerosis with mild lung...

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM)Enrolling: 353 locations
RECRUITINGNCT05345795

Interstitial Lung Disease Trajectories in Patients With Systemic Sclerosis

Systemic sclerosis (SSc) is a heterogeneous systemic autoimmune disease with distinct prognosis according to patients. In patients with systemic sclerosis, interstitial lung...

Sponsor: Central Hospital, Nancy, FranceEnrolling: 6001 location
RECRUITINGNCT07451977

Effects of Oxygen Supplementation During the 6-Minute Walk Test in Chronic Respiratory Failure or Exertional Hypoxemia

The aim of this multicenter crossover trial is to describe the effect of adding a therapeutic dose of exertional oxygen therapy, in terms of exercise performance, gas exchange,...

Sponsor: Istituti Clinici Scientifici Maugeri SpAEnrolling: 1146 locations
RECRUITINGPhase 2NCT06325696

H01 in Adults With Interstitial Lung Disease (The SOLIS Study)

Background: Interstitial lung disease affects the tissues that aid the transfer of oxygen and carbon dioxide between the air and the bloodstream. The disease can cause fibrosis,...

Sponsor: National Institute of Environmental Health Sciences (NIEHS)Enrolling: 371 location
RECRUITINGNCT06644144

P4O2 ILD Extension

The goal of this observational study is to identify early biomarkers that can predict the development of progressive pulmonary fibrosis (PPF) in participants with interstitial...

Sponsor: Amsterdam UMC, location VUmcEnrolling: 4501 location
RECRUITINGPhase 3NCT05943535

Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

Study RIN-PF-305 is designed to evaluate the safety and efficacy of inhaled treprostinil in subjects with progressive pulmonary fibrosis (PPF) over a 52-week period.

Sponsor: United TherapeuticsEnrolling: 69820 locations
RECRUITINGNCT06702228

Precision Diagnosis and Care for Families With Pulmonary Fibrosis in Ireland

This study aims to improve the understanding of how genes and the environment can influence and cause pulmonary fibrosis. By identifying the presence of genes and other factors...

Sponsor: Royal College of Surgeons, IrelandEnrolling: 3001 location
RECRUITINGNCT05681962

Practice of Oxygenation and Respiratory Support During Fiberoptic Bronchoscopy

The current practice of oxygenation and/or ventilation supports in patients undergoing Fiberoptic Bronchoscopy is very heterogeneous among studies published in the literature; in...

Sponsor: University Magna GraeciaEnrolling: 100001 location
RECRUITINGNCT06528418

Identification of Multiple Pulmonary Diseases Using Volatile Organic Compounds Biomarkers in Human Exhaled Breath

The goal of this observational study is to develop an advanced expiratory algorithm model utilizing exhaled breath volatile organic compound (VOC) marker molecules. This model...

Sponsor: ChromX HealthEnrolling: 100001 location
RECRUITINGNCT07283081

Impact of Capillaroscopy in the Investigation of Diffuse Interstitial Pneumonias

The investigators hypothesize that in patients with a new diagnosis of Pulmonary Interstitial Disease (PID), adding capillaroscopy to standard care increases the proportion of...

Sponsor: University Hospital, BordeauxEnrolling: 481 location
RECRUITINGPhase 1 / Phase 2NCT05746039

Feasibility of Semaglutide in Advanced Lung Disease

The goal of this clinical trial is to learn whether semaglutide, an FDA-approved treatment for diabetes and obesity, is feasible and tolerable in patients with advanced lung...

Sponsor: University of PennsylvaniaEnrolling: 81 location
RECRUITINGNCT05392881

Interstitial Lung Disease Research Unit Biobank

Establish a interstitial lung disease (ILD) registry and biorepository to lead towards a further understanding of the disease.

Sponsor: University of Kansas Medical CenterEnrolling: 10001 location
RECRUITINGNCT06326957

Reducing Chronic Breathlessness in Adults by Following a Self-guided, Internet Based Supportive Intervention...

Background: Some health conditions make breathing difficult and uncomfortable. When this happens every day, it is called chronic breathlessness. Over 3 million people living with...

Sponsor: King's College Hospital NHS TrustEnrolling: 2461 location
RECRUITINGNCT06304207

Telehealth and Onsite Maintenance Exercise in Chronic Lung Disease

The goal of this pilot clinical trial is to compare telehealth and onsite supervised maintenance exercise program for adults with Chronic Lung Disease. The specific aims of the...

Sponsor: MGH Institute of Health ProfessionsEnrolling: 301 location
RECRUITINGNCT00258583

Dorothy P. and Richard P. Simmons Center for ILD Research Registry

The purpose of this study is to place past, current, and future medical record information into the UPMC Simmons Center for Interstitial Lung Disease Research Registry.

Sponsor: University of PittsburghEnrolling: 50001 location
RECRUITINGPhase 3NCT05288179

Efficacy and Safety of Pirfenidone Capsules in the Treatment of Pneumoconiosis

This study is a randomized, double-blind, placebo-controlled, multicenter clinical study. The main purpose of this study was to confirm the efficacy and safety of pirfenidone...

Sponsor: Beijing Continent Pharmaceutical Co, Ltd.Enrolling: 2721 location
RECRUITINGNCT04098445

TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT Patients

Hematopoietic stem cell transplant (HSCT) is an effective but toxic therapy and pulmonary morbidity affects as many as 25% of children receiving transplant. Early pulmonary injury...

Sponsor: Children's Hospital Medical Center, CincinnatiEnrolling: 20009 locations
RECRUITINGPhase 2 / Phase 3NCT06125327

SC1011 Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF)

Evaluating Sufenidone (SC1011) in IPF patients for efficacy and safety. Includes screening, treatment, and follow-up, with FVC decline and health checks.

Sponsor: Guangzhou JOYO Pharma Co., LtdEnrolling: 2101 location
RECRUITINGNCT00001532

Role of Genetic Factors in the Development of Lung Disease

This study is designed to evaluate the genetics involved in the development of lung disease by surveying genes involved in the process of breathing and examining the genes in lung...

Sponsor: National Heart, Lung, and Blood Institute (NHLBI)Enrolling: 35002 locations
RECRUITINGNCT05448703

A Study on Predictive Models and Clinical Outcome of Radiation Pneumonitis

Radiation pneumonitis is the main dose-limiting toxicity of thoracic radiotherapy, which can affect life quality, survival, and the tumor-controlling effects of patients receiving...

Sponsor: Huazhong University of Science and TechnologyEnrolling: 3003 locations
RECRUITINGNCT04676828

Functional Lung Avoidance SPECT-guided Radiation Therapy of Lung Cancer

Study aims to determine if functional lung avoidance based on perfusion single photon emission (SPECT)/CT scan, improves toxicity outcomes for patients with advanced lung cancer...

Sponsor: University of AarhusEnrolling: 902 locations
RECRUITINGPhase 3NCT04871191

Study of Salvage Therapy to Treat Patients With Granulomatosis With Polyangiitis

The purpose of this study is to identify the most promising therapeutic strategy for patients with granulomatosis with polyangiitis and inadequate response to standard of care...

Sponsor: Assistance Publique - Hôpitaux de ParisEnrolling: 421 location
RECRUITINGPhase 2NCT06532071

Advanced Imaging for Pulmonary Fibrosis

The purpose of this study is to determine if measurements of active collagen deposition using \[68Ga\]CBP8 positron emission tomography (PET) and tissue injury using dynamic...

Sponsor: Peter CaravanEnrolling: 601 location
RECRUITINGNCT05854563

Cough Capture as a Portal Into the Lung

The lung is a privileged organ; blood does not reflect most lung processes well, if at all. Therefore, for population scale diagnostics, the investigator team is developing...

Sponsor: Albert Einstein College of MedicineEnrolling: 20001 location
RECRUITINGPhase 2NCT06053164

Ambulatory Oxygen Therapy for Individuals With Mild-to-moderate Interstitial Lung Disease

The investigators plan to conduct a study to find out if giving portable oxygen therapy (during physical activity) to patients with interstitial lung disease will improve quality...

Sponsor: University of AlbertaEnrolling: 601 location
RECRUITINGPhase 2NCT07175038

A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With...

This study evaluates the effect of ROC-101 in adults with either Pulmonary Arterial Hypertension (PAH) or Pulmonary Hypertension Associated with Interstitial Lung Disease...

Sponsor: AllRock Bio, Inc.Enrolling: 4013 locations
RECRUITINGNCT06069115

Radiotherapy Exposed Lung Injury: Effect on Functioning - Cohort

Prospective cohort research to study the state of oxygen metabolism, reserve capabilities of cardiovascular and respiratory systems in patients with breast cancer to create a...

Sponsor: Meshalkin Research Institute of Pathology of CirculationEnrolling: 2001 location
RECRUITINGNCT06732674

Home Based Clinical Management of Interstitial Lung Disease in Systemic Rheumatic Diseases

The RMD-mILDer trial is a home monitoring strategy trial aiming to improve management of interstitial lung disease related to rheumatic diseases applying eHealth technology. It...

Sponsor: Oslo University HospitalEnrolling: 2181 location
RECRUITINGPhase 2NCT06736990

A Phase 2 Study of CAL101 in Patients With Idiopathic Pulmonary Fibrosis

The goal of this clinical trial is to learn if the investigational drug CAL101 can help prevent further decline in lung function in adults with Idiopathic Pulmonary Fibrosis....

Sponsor: Calluna Pharma ASEnrolling: 15020 locations
RECRUITINGEarly Phase 1NCT06267183

A Clinical Study to Evaluate Safety, Tolerability and Pharmacokinetics of SV001 in Chinese Healthy Adult Volunteers.

The purpose of this study is to evaluate safety, tolerability, PK and immunogenicity of SV001 compare to placebo in Chinese healthy adult volunteers.

Sponsor: Shanghai Synvida Biotechnology Co.,Ltd.Enrolling: 531 location
RECRUITINGNCT06323876

The Role of Quantitative CT and Radiomic Biomarkers for Precision Medicine in Pulmonary Fibrosis

This observational study involves obtaining 2 chest CT scans; a historical baseline CT within ±1 year of enrollment into PRECISIONS, and a follow-up CT (either historical or...

Sponsor: University of VirginiaEnrolling: 1601 location
RECRUITINGPhase 2NCT06868290

Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Severe Active GPA or MPA

The purpose of this study is to evaluate the efficacy and safety of rapcabtagene autoleucel versus comparator in participants with severe active Granulomatosis with Polyangiitis...

Sponsor: Novartis PharmaceuticalsEnrolling: 12620 locations
RECRUITINGNCT06965322

Study on the Detection of Pleuropulmonary Manifestations in Rheumatoid Arthritis

The aim of the study is to develop a standardized, risk-adapted screening protocol for detecting pleuropulmonary manifestations in patients with rheumatoid arthritis. To assess...

Sponsor: Medical University InnsbruckEnrolling: 8001 location
RECRUITINGPhase 2NCT06205121

Efficacy and Safety Study of OATD-01 in Patients With Active Pulmonary Sarcoidosis

This is a Phase 2, randomized, double-blind, placebo-controlled, adaptive, multicenter study to evaluate the efficacy, safety, tolerability, Pharmacodynamics (PD), and...

Sponsor: Molecure S.A.Enrolling: 9620 locations
RECRUITINGPhase 1NCT07407543

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SRN001 in Healthy Korean and...

To evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of repeated doses of SRN001 in healthy adult volunteers.

Sponsor: siRNAgen Therapeutics Inc.Enrolling: 301 location
RECRUITINGPhase 2NCT06951217

An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)

This is an open-label extension study for participants who were previously enrolled in and completed an Avalyn Pharma Sponsored study with an inhaled antifibrotic, such as AP01....

Sponsor: Avalyn Pharma Inc.Enrolling: 34020 locations
RECRUITINGPhase 2NCT06475781

Study to Evaluate Safety and Efficacy of Mirivadelgat in PH-ILD

The goal of this clinical trial is to see if mirivadelgat will work in patients with Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD). It will also learn...

Sponsor: Foresee Pharmaceuticals Co., Ltd.Enrolling: 1269 locations
RECRUITINGPhase 3NCT07299695

Intravenous Immunoglobulin for the Treatment of Acute Exacerbations of Idiopathic Pulmonary Fibrosis

Acute exacerbations of idiopathic pulmonary fibrosis (AE-IPF) are sudden and severe worsening episodes that can be life-threatening. Currently, no treatment has been proven to...

Sponsor: Argyrios TzouvelekisEnrolling: 1961 location
RECRUITINGNCT07486206

Optimizing the Follow-Up Journey in Interstitial Lung Disease: The OPTIMIZE-ILD-2 Trial

The OPTIMIZE-ILD-2 trial is a prospective, randomized, open-label clinical trial designed to evaluate the impact of a coordinated follow-up pathway on patients with established...

Sponsor: Hospital de GranollersEnrolling: 1521 location

Showing 50 of 104 trials.Search all Interstitial Lung Disease trials